erlotinib hydrochloride has been researched along with norcantharidin in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (norcantharidin) | Trials (norcantharidin) | Recent Studies (post-2010) (norcantharidin) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 272 | 0 | 188 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | norcantharidin (IC50) |
|---|---|---|---|
| PPP5C protein, partial | Homo sapiens (human) | 2.567 | |
| serine/threonine-protein phosphatase PP1-alpha catalytic subunit isoform 3 | Homo sapiens (human) | 2.832 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, FR; Li, W; Liu, ZY; Shen, M; Tao, M; Wang, WJ; Wu, MY; Zhi, Q | 1 |
1 other study(ies) available for erlotinib hydrochloride and norcantharidin
| Article | Year |
|---|---|
Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib.
Topics: Apoptosis; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cantharidin; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Erlotinib Hydrochloride; Gemcitabine; Humans; Neoplastic Stem Cells; Pancreatic Neoplasms; Phosphorylation; Signal Transduction | 2015 |